CURRICULUM VITAE MICHAEL I. KOUKOURAKIS

Cancer. 2001 Dec;34 Suppl 2:S83-9. PubMed PMID: 11720747.
150: Koukourakis MI, Yannakakis D. High dose daily amifostine and
hypofractionated intensively accelerated radiotherapy for locally advanced breast
cancer. A phase I/II study and report on early and late sequellae. Anticancer
Res. 2001 Jul-Aug;21(4B):2973-8. PubMed PMID: 11712796.
151: Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos K, Pastorek J,
Wykoff CC, Gatter KC, Harris AL. Hypoxia-regulated carbonic anhydrase-9 (CA9)
relates to poor vascularization and resistance of squamous cell head and neck
cancer to chemoradiotherapy. Clin Cancer Res. 2001 Nov;7(11):3399-403. PubMed
PMID: 11705854.
152: Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter
KC, Harris AL. Expression of hypoxia-inducible carbonic anhydrase-9 relates to
angiogenic pathways and independently to poor outcome in non-small cell lung
cancer. Cancer Res. 2001 Nov 1;61(21):7992-8. PubMed PMID: 11691824.
153: Koukouraki S, Koukourakis MI, Vagios E, Velidaki A, Tsiftsis D, Karkavitsas
N. The role of 99m Tc-sestamibi scintimammography and colour Doppler
ultrasonography in the evaluation of breast lesions. Nucl Med Commun. 2001
Nov;22(11):1243-8. PubMed PMID: 11606891.
154: Kakolyris S, Giatromanolaki A, Koukourakis M, Powis G, Souglakos J, Sivridis
E, Georgoulias V, Gatter KC, Harris AL. Thioredoxin expression is associated with
lymph node status and prognosis in early operable non-small cell lung cancer.
Clin Cancer Res. 2001 Oct;7(10):3087-91. PubMed PMID: 11595699.
155: Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F,
Gatter KC, Harris AL. Relation of hypoxia inducible factor 1 alpha and 2 alpha in
operable non-small cell lung cancer to angiogenic/molecular profile of tumours
and survival. Br J Cancer. 2001 Sep 14;85(6):881-90. PubMed PMID: 11556841;
PubMed Central PMCID: PMC2375073.
156: Giatromanolaki A, Koukourakis MI, Sivridis E, Thorpe PE, Brekken RA,
Konstantinos S, Fountzilas G, Gatter KC, Harris AL. Tumor specific activation of
the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell
head and neck carcinomas. Clin Exp Metastasis. 2000;18(4):313-9. PubMed PMID:
11448062.
157: Papadopoulos I, Sivridis E, Giatromanolaki A, Koukourakis MI. Tumor
angiogenesis is associated with MUC1 overexpression and loss of prostate-specific
antigen expression in prostate cancer. Clin Cancer Res. 2001 Jun;7(6):1533-8.
27